Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Acquires 17,500 Shares of Stock

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder bought 17,500 shares of the company’s stock in a transaction on Friday, March 13th. The shares were bought at an average cost of $5.73 per share, for a total transaction of $100,275.00. Following the transaction, the director directly owned 119,731 shares in the company, valued at approximately $686,058.63. This represents a 17.12% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Senseonics Holdings, Inc. Common Stock Trading Up 11.9%

Shares of NASDAQ:SENS opened at $6.31 on Tuesday. The firm has a market capitalization of $263.57 million, a PE ratio of -3.73 and a beta of 0.90. The company has a current ratio of 4.83, a quick ratio of 4.55 and a debt-to-equity ratio of 0.58. Senseonics Holdings, Inc. Common Stock has a 12-month low of $5.25 and a 12-month high of $15.74.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Stifel Nicolaus set a $9.00 target price on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday, March 3rd. TD Cowen reissued a “buy” rating on shares of Senseonics Holdings, Inc. Common Stock in a research report on Thursday, January 8th. Finally, Weiss Ratings assumed coverage on Senseonics Holdings, Inc. Common Stock in a research note on Tuesday, February 17th. They set a “sell (d-)” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Senseonics Holdings, Inc. Common Stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.70.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. grew its position in Senseonics Holdings, Inc. Common Stock by 26.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 612,534 shares of the company’s stock worth $402,000 after purchasing an additional 127,086 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Senseonics Holdings, Inc. Common Stock by 26.6% in the second quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock worth $4,147,000 after buying an additional 1,828,302 shares during the last quarter. Sio Capital Management LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter worth $2,312,000. JBR Co Financial Management Inc acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth $65,000. Finally, Walleye Capital LLC acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth $539,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.